Abstract
SARS-CoV-2 is the third and largest pandemic that emerged in Wuhan city, Hubei province, China in 2019. As per WHO 45,988,595 people have been infected and the COVID 19 has caused more than 1,194,979 deaths. The clinical spectrum of COVID 19 varies from asymptomatic presentation to multi-organ dysfunction. The pathophysiology behind the sequel of COVID 19 immuno-suppression is an area yet to be explored. Here, we report a case of 52 year old male with persistent pyrexia post his recovery from COIVD-19. On further evaluation, a diagnosis of amoebic liver abscess that resulted as a sequel of COVID-19 was made.
Highlights
SARS-CoV-2 is the third and largest pandemic that emerged in Wuhan city, Hubei province, China in 2019
# Postgraduate; ⱷ Professor; † Associate Professor; *Corresponding author: E-mail: docnathan82@gmail.com; Pandiyan et al.; JPRI, 33(55B): 241-244, 2021; Article no.JPRI.76626 to entamoeba have not been widely documented as per our extensive search through literature. We present this rare case of amoebic liver abscess post recovery from COVID 19 [5]
Of note, when patients present with amoebic liver abscesses, their stool microscopy is often negative for E. histolytica, so stool microscopy cannot be relied upon for making the diagnosis, a positive test is helpful [7]
Summary
Asymptomatic to severe illness [1]. The complications of amoebiasis may be intestinal or Amoebiasis, a common parasitic infection extra intestinal.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
